Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra)

By Shabsigh R.   Padma-Nathan H.   Gittleman M.   McMurray J.   Kaufman J.   Goldstein I.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 477-480

Elsevier

Access to resources Recommend Favorite

Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury - a preliminary report

By Bodner D.R.   Haas C.A.   Krueger B.   Seftel A.D.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil

By Hellstrom W.J.G.   Bennett A.H.   Gesundheit N.   Kaiser F.E.   Lue T.F.   Padma-Nathan H.   Peterson C.A.   Tam P.Y.   Todd L.K.   Varady J.C.   Place V.A.  

Urology, Vol. 48, Iss. 6, 1996-12 ,pp. : 851-856

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction

By Goldstein I.   Payton T.R.   Schechter P.J.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 301-305

Elsevier

Access to resources Recommend Favorite

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction

By Rosen R.C.   Riley A.   Wagner G.   Osterloh I.H.   Kirkpatrick J.   Mishra A.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 822-830

Elsevier

Access to resources Recommend Favorite